📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer. (2021)

First Author: O'Leary B

Attributed to: MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jnci/djaa087

PubMed Identifier: 32940689

Publication URI: http://europepmc.org/abstract/MED/32940689

Type: Journal Article/Review

Volume: 113

Parent Publication: Journal of the National Cancer Institute

Issue: 3

ISSN: 0027-8874